Search Results

WoundExpress aids in the treatment of the following clinical conditions:

• Chronic wounds including leg ulcers (venous leg ulcers and mixed aetiology leg ulcers)
• The management of lower limb pain

The WoundExpress Therapy Device is an intermittent pneumatic compression system consisting of a pump unit and a thigh garment, interconnected by a detachable three chamber tube set. It is a non-invasive mechanical system designed to enhance blood and lymph flow as a therapy to manage the clinical condition listed above. The pump is a portable, ac mains powered device, that produces a pre-set pneumatic therapy cycle delivered through a 3 port output connector, which is connected to a three chamber garment that is applied to the patient thigh. The pump operates on a 4 minute automatically timed gradient pressure sequence, consisting of a 2 minute venous emptying phase and a 2 minute rest phase. The venous emptying phase consists of six 20 second compression cycles, while no compression takes place during the rest phase. Each 20 second compression cycle is characterised by overlapping synchronous inflations and deflations of the distal (lower), central (middle) and proximal (upper) chambers.

The provided document is an FDA 510(k) Premarket Notification for the WoundExpress device. This type of submission focuses on demonstrating substantial equivalence to a legally marketed predicate device, rather than proving a new device's safety and efficacy through extensive clinical studies with specific performance acceptance criteria like those seen for novel drug or high-risk medical device approvals.

Therefore, the document does not contain the information requested regarding acceptance criteria and a study proving the device meets those criteria, as typically understood for a new and complex AI/software-as-a-medical-device (SaMD) or drug study.

Specifically:

• There is no table of acceptance criteria and reported device performance as the performance data section focuses on engineering verification and validation testing (biocompatibility, electrical safety, mechanical, functional, etc.) to ensure the device performs as intended and is safe, rather than clinical performance against specific metrics like sensitivity/specificity for a diagnostic AI.
• No sample size used for a test set (clinical data), data provenance, number of experts, adjudication methods, MRMC studies, or standalone algorithm performance are described because this is a physical medical device (compressible limb sleeve), not an AI algorithm. Its performance is related to its mechanical and physiological function, not diagnostic accuracy based on image analysis or similar AI tasks.
• There is no notion of "ground truth" establishment for a test set or training set in the context of AI. The "validation study" mentioned in the Performance Data section is likely a non-clinical/engineering validation to ensure the device meets its design specifications and intended use, not a clinical trial establishing ground truth for AI model training or evaluation.
• No sample size for a training set is applicable as this is not an AI/ML device.

The document states:

• "The WoundExpress has undergone a validation study to ensure the device can achieve its intended use. The validation concluded the device is fit for purpose and the clinical benefits of the device outweighs the overall residual risk." (Page 7)
• Under "Performance Data," various types of engineering and safety testing are listed: Biocompatibility, Electronic Hardware Testing, Mechanical Testing, Functional Testing, Performance Testing (general validation as above), Electrical Safety Testing, EMC Testing, Environmental Performance Testing. These are standard tests for physical medical devices to demonstrate safety and proper function, not clinical efficacy or diagnostic accuracy.

In summary, the provided FDA 510(k) notification for the WoundExpress device does not offer the kind of detailed information about acceptance criteria and clinical study performance (especially related to AI/ML or diagnostic accuracy) that your questions are looking for. This is because the device is a physical, mechanical system (compressible limb sleeve) cleared under the substantial equivalence pathway, which relies on demonstrating similarity to existing devices and adequate non-clinical testing, rather than novel clinical performance metrics.

Ask a specific question about this device